Skip to main content

Glimpse Group Inc

For the period ended Dec 31, 2023. Filed Feb 14, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2023 · Filed Feb 14, 2024

BTLN$3.67+4.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

For the Six Months Ended December 31,
2023 · 2022
Cash flows from operating activities:
Net loss$(857,810)$(4,074,362)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization and depreciation720,4581,056,131
Common stock and stock option based compensation for employees and board of directors1,135,0481,717,462
Accrued non cash performance bonus fair value adjustment(551,234)-
Acquisition contingent consideration fair value adjustment(4,025,544)(2,625,102)
Impairment of intangible assets901,204-
Issuance of common stock to vendors as compensation73,282-
Adjustment to operating lease right-of-use assets and liabilities(89,376)(6,383)
Changes in operating assets and liabilities:
Accounts receivable208,052(373,055)
Deferred costs/contract assets81,560482,133
Prepaid expenses and other current assets(99,231)(130,336)
Other assets(1,507)30,100
Accounts payable(180,077)(439,737)
Accrued liabilities(343,474)(7,425)
Deferred revenue/contract liabilities(329,531)(2,123,680)
Net cash used in operating activities(3,358,180)(6,494,254)
Cash flow from investing activities:
Purchases of equipment(8,751)(119,588)
Acquisitions, net of cash acquired-(2,478,756)
Proceeds from maturity of investments-2,738
Net cash used in investing activities(8,751)(2,595,606)
Cash flows provided by financing activities:
Proceeds from securities purchase agreement, net2,968,501-
Proceeds from exercise of stock options-44,916
Cash provided by financing activities2,968,50144,916
Net change in cash, cash equivalents and restricted cash(398,430)(9,044,944)
Cash, cash equivalents and restricted cash, beginning of year5,619,08318,249,666
Cash, cash equivalents and restricted cash, end of period$5,220,653$9,204,722
Non-cash Investing and Financing activities:
Issuance of common stock for satisfaction of contingent liability$127,145$734,036
Issuance of common stock for non cash performance bonus$127,145$-
Lease liabilities arising from right-of-use assets$113,182$1,155,769
Note receivable for sale of subsidiary assets$1,000,000$-
Allowance against note receivable$(1,000,000)$-
Common stock issued for acquisition$-$2,846,144
Contingent acquisition consideration liability recorded at closing$-$6,139,000
Common stock issued for purchase of intangible asset - technology$-$326,436
Issuance of common stock for satisfaction of contingent liability, net of note extinguishment$-$318,571
Extinguishment of note receivable for satisfaction of contingent liability$-$250,000
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.